Paper22706128
Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation.
Herreros MD and 5 others. Dis Colon Rectum, 2012. Cited by 211 papers, by iCite.
Cite this record
ConductScience Library. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Papers, record 22706128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22706128
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation.
- PubMed
- Publication types
- Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adipocytes | Major topic |
| Fibrin Tissue Adhesive | Major topic |
| Mesenchymal Stem Cell Transplantation | Major topic |
| Rectal Fistula | Major topic |
| Tissue Adhesives | Major topic |
| Adult | |
| Combined Modality Therapy | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Single-Blind Method | |
| Spain | |
| Transplantation, Autologous | |
| Treatment Outcome |
Source PubMed
Trials5
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00475410 | Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT01020825 | Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled Trial | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT04660903 | Treatment of Fistula in Ano With Autologous Fatty Tissue Cells Transplantation | Background | ClinicalTrials.gov | |
| NCT04750499 | Treatment of Perianal Fistulas by Endorectal Advancement Flap Associated With Adipose Tissue Injection | Background | ClinicalTrials.gov | |
| NCT05201209 | LASER FiLaC™ (FISTULA LASER CLOSURE) : First-line Treatment of Complex Anal Fistulas | Background | ClinicalTrials.gov |
Cited by127
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42332719 | Use of microfragmented autologous adipose tissue (LIPOGEMS®) as a sphincter-saving therapy for complex anal fistulas: a single-center retrospective study. | BMC Surg | 2026 | https://conductscience.org/library/papers/42332719 | PubMed |
| 42149263 | Efficacy and safety of freshly collected autologous adipose tissue for complex anal fistulas in non-IBD patients: a prospective cohort study. | Tech Coloproctol | 2026 | https://conductscience.org/library/papers/42149263 | PubMed |
| 41968436 | Effect of polydeoxyribonucleotide as a potential therapeutic agent to enhance the healing of Crohn's perianal fistula. | Inflamm Bowel Dis | 2026 | https://conductscience.org/library/papers/41968436 | PubMed |
| 41821809 | Current status and clinical applications of tissue engineering of the gastrointestinal tract: a systematized narrative review. | Front Gastroenterol (Lausanne) | 2023 | https://conductscience.org/library/papers/41821809 | PubMed |
| 41782164 | Repairing Peri-Anal Fistulas with regenerative cell therapeutics: study protocol for a double-blinded randomized controlled phase I-II trial from Denmark (REP-PAF). | Trials | 2026 | https://conductscience.org/library/papers/41782164 | PubMed |
| 41389226 | Research progress of stem cell transplantation in the treatment of anal fistula. | Surg Today | 2026 | https://conductscience.org/library/papers/41389226 | PubMed |
| 41357640 | Evidence outside the box: Minimally invasive treatment for anal fistula. | World J Gastrointest Surg | 2025 | https://conductscience.org/library/papers/41357640 | PubMed |
| 41023905 | Rapidly decellularized adipose tissue induces soft tissue vascularization in potential anatomical spaces. | BMC Biotechnol | 2025 | https://conductscience.org/library/papers/41023905 | PubMed |
| 40933558 | Adipose-derived stem cell therapies for complex anal fistula: a systematic review and meta-analysis of randomized controlled trials. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40933558 | PubMed |
| 40442569 | Systematic review and network meta-analysis of cryptoglandular complex anal fistula treatment: evaluation of surgical strategies. | Updates Surg | 2025 | https://conductscience.org/library/papers/40442569 | PubMed |
| 40205247 | Systematic review and meta-analysis of the efficacy and safety of stem cell treatment of anal fistulas. | Tech Coloproctol | 2025 | https://conductscience.org/library/papers/40205247 | PubMed |
| 39944001 | Horizon scanning: new and future therapies in the management of inflammatory bowel disease. | eGastroenterology | 2023 | https://conductscience.org/library/papers/39944001 | PubMed |
| 39720270 | Long-term efficacy of mesenchymal stem cell treatment for complex perianal fistulas: A systematic review and meta-analysis. | Cent Eur J Immunol | 2024 | https://conductscience.org/library/papers/39720270 | PubMed |
| 39403342 | Refractory Crohn's Disease: Perspectives, Unmet Needs and Innovations. | Clin Exp Gastroenterol | 2024 | https://conductscience.org/library/papers/39403342 | PubMed |
| 38980511 | Efficacy of injection of autologous adipose tissue in the treatment of patients with complex and recurrent fistula-in-ano of cryptoglandular origin. | Tech Coloproctol | 2024 | https://conductscience.org/library/papers/38980511 | PubMed |
| 38682120 | Hyperbaric Oxygen Therapy for Refractory Perianal Crohn's Disease: A Case Report. | Gastroenterol Hepatol (N Y) | 2024 | https://conductscience.org/library/papers/38682120 | PubMed |
| 38550268 | Optimum management for complex anal fistula: A network meta-analysis of randomized controlled trials. | Surg Open Sci | 2024 | https://conductscience.org/library/papers/38550268 | PubMed |
| 37904247 | Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study. | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/37904247 | PubMed |
| 37700821 | Up-to-date meta-analysis of long-term evaluations of mesenchymal stem cell therapy for complex perianal fistula. | World J Stem Cells | 2023 | https://conductscience.org/library/papers/37700821 | PubMed |
| 37485563 | The Impact of Cellular Therapies on Gastrointestinal Diseases: Applications and Challenges. | Turk J Gastroenterol | 2023 | https://conductscience.org/library/papers/37485563 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22706128
GET https://conductscience.org/api/papers/v1/22706128/cited_by?page=2